Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research Article

Detection of 22q11.2 Deletion Among 139 Patients with Di George/Velocardiofacial Syndrome Features

S. KITSIOU-TZELI, A. KOLIALEXI, H. FRYSSIRA, A. GALLA-VOUMVOURAKI, K. SALAVOURA, M. KANARIOU, G.TH. TSANGARIS, E. KANAVAKIS and A. MAVROU
In Vivo September 2004, 18 (5) 603-608;
S. KITSIOU-TZELI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. KOLIALEXI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. FRYSSIRA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. GALLA-VOUMVOURAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. SALAVOURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. KANARIOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G.TH. TSANGARIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. KANAVAKIS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. MAVROU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Cytogenetic and FISH analysis was performed in 139 patients to detect the pathognomonic of Di George/Velocardiofacial syndrome (DGS/VFCS) deletion 22q11.2. An abnormal karyotype was revealed in 2/139 cases (47, XXY and 46, XX, 2p+). A deletion was found in 17/139 (12.2%) patients (14 males/ 3 females), inherited in 3 (2 maternal and 1 paternal). Patients with 22q11.2 deletion exhibited facial dysmorphic features (82%), congenital heart defects (70%), immunological problems (47%), multiple congenital anomalies (64%), hypocalcemia (47%), mental retardation/learning difficulties (35%), cleft palate/ velopharyngeal insufficiency (23.5%), seizures/hypotonia (23%) and growth retardation (12%). Among 56/139 patients with detailed available clinical data, the 22q11.2 deletion was confirmed in all cases with hypocalcemia and in over half of the cases with multiple congenital anomalies, immunological problems and hypotonia/seizures (70%, 60% and 57%, respectively). Genetic reevaluation of 39 patients without the 22q11.2 deletion contributed to the classification of 14 (37%) under different syndromes, emphasizing the need for stricter referral criteria.

Footnotes

    • Received May 25, 2004.
    • Accepted August 6, 2004.
  • Copyright © 2004 The Author(s). Published by the International Institute of Anticancer Research.
PreviousNext
Back to top

In this issue

In Vivo
Vol. 18, Issue 5
September-October 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Detection of 22q11.2 Deletion Among 139 Patients with Di George/Velocardiofacial Syndrome Features
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
14 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Detection of 22q11.2 Deletion Among 139 Patients with Di George/Velocardiofacial Syndrome Features
S. KITSIOU-TZELI, A. KOLIALEXI, H. FRYSSIRA, A. GALLA-VOUMVOURAKI, K. SALAVOURA, M. KANARIOU, G.TH. TSANGARIS, E. KANAVAKIS, A. MAVROU
In Vivo Sep 2004, 18 (5) 603-608;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Detection of 22q11.2 Deletion Among 139 Patients with Di George/Velocardiofacial Syndrome Features
S. KITSIOU-TZELI, A. KOLIALEXI, H. FRYSSIRA, A. GALLA-VOUMVOURAKI, K. SALAVOURA, M. KANARIOU, G.TH. TSANGARIS, E. KANAVAKIS, A. MAVROU
In Vivo Sep 2004, 18 (5) 603-608;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  • 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
  • Google Scholar
In Vivo

© 2026 In Vivo

Powered by HighWire